Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TLM-004 by Therillume for Glioblastoma Multiforme (GBM): Likelihood of Approval
TLM-004 is under clinical development by Therillume and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...